Skip navigation

Innovative Contracting and Pricing Strategies in an Ultra-Competitive and Evolving Healthcare System

January 24-25, 2018
  • Philadelphia, PA

Now in its fifth year, CBI’s Reimbursement and Contracting conference provides a platform for bio/pharmaceutical manufacturers to unravel complexities associated with reimbursement, pricing strategies and federal and commercial contracting. As pricing pressures and competition continue to mount, reimbursement, pricing and contract teams must navigate evolving regulatory landscapes to develop innovative and competitive pricing strategies. Join industry thought-leaders to discuss the latest on the impact of value-based contracting, Medicare Part B and Part D, ACOs and IDNs, 340B, repeal and replace and much more!


  • Navigate the latest healthcare updates and implications for
    contracting and reimbursement
  • Align new technologies and treatment paradigms and
    AI technologies
  • Uncover leading contracting and pricing strategies for
    optimized reimbursement
  • Overcome key challenges for specialty products and biosimilars
  • Shine light on value-based contracting from a payers perspective
  • Benefit from an in-depth case study on outcomes-based
    contracting — What happens after the signature?


Excellent conference to bring
the commercial and government contracting
perspectives together.

Department Director, Government Contracts & Reporting, Bayer

Extremely well run conference where
ideas were shared so everyone could benefit
and learn from the group!

Business Relations Manager, Sanofi Genzyme

The in-depth introduction of pros and cons for
outcomes-based contracting opened the
door for exploration

Senior Business Partner, Indivior